Evidence map›Paper›PMID 36948848›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Demographic characteristics and associated influencing factors in treated patients with chronic hepatitis B with hypoviremia : a single-center retrospective cross-sectional study].

T Li, Y Kong, Y Y Liu, T F Liu, A D Ma, L Q Li, Z Y Pei, L Y Zhang

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

T LiDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
Y KongDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
Y Y LiuDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
T F LiuDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
A D MaDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
L Q LiDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
Z Y PeiDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
L Y ZhangDepartment of Hepatology, Second Hospital, Lanzhou University, Lanzhou 730030, China.
Lanzhou University Second Hospital · CN

Funding

Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital CY2018-BJ17, CY2021-QN-A18Natural Science Foundation of Gansu Province, China 21JR1RA146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicAdultAntiviral AgentsCross-Sectional StudiesDemographyDNA, ViralHepatitis B e AntigensHepatitis B virusHumansRetrospective StudiesAntiviral AgentsDNA, ViralHepatitis B e AntigensChronic hepatitis BLow-level viremiaNucleos(t)ide analoguesRisk factors

Identifiers

PMID36948848
PMCPMC12813816
OpenAlexW4360600776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.